Allakos Competitors, Revenue, Alternatives and Pricing
Estimated Revenue & Financials
- Allakos's estimated annual revenue is currently $6.5M per year.
- Allakos received $100.0M in venture funding in December 2017.
- Allakos's estimated revenue per employee is $61,415
- Allakos's total funding is $270.5M.
- Allakos has 106 Employees.
- Allakos grew their employee count by 43% last year.
- Allakos currently has 10 job openings.
|Competitor Name||Revenue||Number of Employees||Employee Growth||Total Funding||Online Review||Pricing|
What Is Allakos?
Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.keywords:Biotechnology,Cleantech,Healthcare,Marketing,Pharmaceuticals,Wind Power
Number of Employees
Employee Growth %
As of late, it has definitely been a great time to be an investor Allakos Inc. ALLK. The stock has moved higher by 1.6% in the past month, while it ...
SG Americas Securities LLC increased its stake in shares of Allakos Inc (NASDAQ:ALLK) by 27.5% during the 2nd quarter, according to the ...
Tracking the present quarter EPS consensus estimate for Allakos Inc. (:ALLK), we have noted the current number is -.45. This EPS estimate is ...
|2017-12-14||$100.0M||A||New Enterprise Associates||Article|
Allakos Executive Hires
|2014-10-02||Alejandro Dorenbaum||Chief Medical Officer||Article|
|2016-01-20||Simon Greenwood||Chief Business Officer||Article|